Skip to main content
Inflammatory Bowel DiseasesGut health

What this study is

This prospective, non-interventional research registry is designed to study the comparative effectiveness and comparative safety of approved treatments for IBD in a cohort of patients cared for by gastroenterologists across North America. Secondary objectives include analyzing the epidemiology and natural history of the disease, its comorbidities, and current treatment practices.

Study details

Sponsor
CorEvitas
Conditions
Inflammatory Bowel Diseases
Enrolling
2,287 people
Starts
2017-03-27
Est. completion
2100-12
Record
View on ClinicalTrials.gov ↗